• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤恶性黑色素瘤下方未受累真皮厚度的研究:未受累真皮与肿瘤厚度之比(DT:TT)作为一项预后指标。

A study of the thickness of uninvolved dermis beneath cutaneous malignant melanoma: the ratio of uninvolved dermis to tumour thickness (DT:TT) as a prognostic index.

作者信息

Saxby P J, Griffiths R W, Corbishley C M, Briggs J C

出版信息

Br J Plast Surg. 1984 Oct;37(4):496-500. doi: 10.1016/0007-1226(84)90138-3.

DOI:10.1016/0007-1226(84)90138-3
PMID:6498387
Abstract

The histological material from 147 patients treated for clinical stage I primary cutaneous malignant melanoma between 1968 and 1972 was reviewed. All patients had a minimum follow up of 10 years. Measurements were made of the thickness of uninvolved dermis (DT) deep to the tumour and the tumour thickness (TT) itself. The ratio of dermal thickness: tumour thickness (DT:TT) was correlated with clinical progress at follow-up and compared as a prognostic index with tumour thickness alone. The ratio DT:TT was found to be a useful prognostic guide, a value of greater than 2.0 proving to be a very favourable sign. It is suggested that this simple ratio should be routinely reported in all cases of primary cutaneous malignant melanoma to provide an additional index with a view to assessing its value as a prognostic guide.

摘要

回顾了1968年至1972年间接受治疗的147例临床I期原发性皮肤恶性黑色素瘤患者的组织学资料。所有患者的最短随访时间为10年。测量肿瘤深部未受累真皮的厚度(DT)和肿瘤本身的厚度(TT)。真皮厚度与肿瘤厚度之比(DT:TT)与随访时的临床进展相关,并作为预后指标与单独的肿瘤厚度进行比较。发现DT:TT比值是一个有用的预后指标,大于2.0的值被证明是一个非常有利的迹象。建议在所有原发性皮肤恶性黑色素瘤病例中常规报告这个简单的比值,以提供一个额外的指标,以便评估其作为预后指标的价值。

相似文献

1
A study of the thickness of uninvolved dermis beneath cutaneous malignant melanoma: the ratio of uninvolved dermis to tumour thickness (DT:TT) as a prognostic index.皮肤恶性黑色素瘤下方未受累真皮厚度的研究:未受累真皮与肿瘤厚度之比(DT:TT)作为一项预后指标。
Br J Plast Surg. 1984 Oct;37(4):496-500. doi: 10.1016/0007-1226(84)90138-3.
2
Clinical course of cutaneous malignant melanoma related to histopathological criteria of primary tumour.
Scand J Plast Reconstr Surg. 1980;14(3):229-34. doi: 10.3109/02844318009106715.
3
Prognostic value of tumour thickness in cutaneous malignant melanoma.肿瘤厚度在皮肤恶性黑色素瘤中的预后价值。
J Clin Pathol. 1983 Jan;36(1):51-6. doi: 10.1136/jcp.36.1.51.
4
Experience of thin cutaneous melanomas (less than 0.76 mm and less than 0.85 mm thick) in a large plastic surgery unit: a 5 to 17 year follow-up.
Br J Plast Surg. 1984 Oct;37(4):501-6. doi: 10.1016/0007-1226(84)90139-5.
5
Long term follow-up in cutaneous malignant melanoma: the relationship of maximal tumour thickness to disease free survival, disease recurrence and death.皮肤恶性黑色素瘤的长期随访:最大肿瘤厚度与无病生存期、疾病复发及死亡的关系。
Br J Plast Surg. 1984 Oct;37(4):507-13. doi: 10.1016/0007-1226(84)90140-1.
6
Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.原发性皮肤恶性黑色素瘤的浸润深度和肿瘤厚度。一项对2012例病例的研究。
Acta Pathol Microbiol Immunol Scand A. 1985 Mar;93(2):49-55.
7
Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.恶性黑色素瘤的临床病理特征及预后因素:拉玛蒂博迪医院泰国患者的回顾性分析
J Med Assoc Thai. 2015 Aug;98(8):820-7.
8
Prognostic index for cutaneous melanoma: an analysis after follow-up of 2715 patients.皮肤黑色素瘤的预后指数:对2715例患者随访后的分析
Melanoma Res. 2001 Dec;11(6):619-26. doi: 10.1097/00008390-200112000-00008.
9
Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation.
Dermatol Clin. 1991 Oct;9(4):643-8.
10
A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.一项回顾性观察研究,比较仅接受切除术治疗的原发性皮肤恶性黑色素瘤患者与先行切除活检再行更广泛局部切除的患者。
Br J Dermatol. 2004 Mar;150(3):523-30. doi: 10.1111/j.1365-2133.2004.05849.x.